Glucocorticoid/NN
receptor/NN
characteristics/NNS
in/IN
monocytes/NNS
of/IN
patients/NNS
with/IN
corticosteroid-resistant/JJ
bronchial/JJ
asthma/NN
./.

The/DT
mechanism/NN
of/IN
corticosteroid/NN
resistance/NN
in/IN
bronchial/JJ
asthma/NN
has/VBZ
been/VBN
studied/VBN
by/IN
determining/VBG
the/DT
rank/NN
order/NN
of/IN
potency/NN
for/IN
different/JJ
corticosteroids/NNS
in/IN
inhibiting/VBG
the/DT
generation/NN
of/IN
a/DT
3/CD
kD/NN
molecule/NN
from/IN
peripheral/JJ
blood/NN
monocytes/NNS
isolated/VBN
from/IN
corticosteroid-sensitive/JJ
(/(
CS/JJ
)/)
and/CC
corticosteroid-resistant/JJ
(/(
CR/JJ
)/)
asthmatic/JJ
subjects/NNS
,/,
which/WDT
augments/VBZ
leukotriene/NN
B4/NN
(/(
LTB4/NN
)/)
generation/NN
by/IN
human/JJ
neutrophils/NNS
(/(
PMN/NN
)/)
stimulated/VBN
by/IN
calcium/NN
ionophore/NN
./.
=====
In/IN
addition/NN
,/,
binding/VBG
studies/NNS
with/IN
(/(
3H/NN
)/)
dexamethasone/NN
have/VBP
been/VBN
performed/VBN
to/TO
determine/VB
the/DT
dissociation/NN
constant/NN
(/(
Kd/NN
)/)
and/CC
receptor/NN
numbers/NNS
(/(
Ro/NN
)/)
in/IN
the/DT
monocytes/NNS
of/IN
these/DT
two/CD
groups/NNS
of/IN
subjects/NNS
./.
=====
The/DT
concentration/NN
of/IN
corticosteroid/NN
producing/VBG
50/CD
%/NN
inhibition/NN
(/(
IC50/NN
)/)
was/VBD
600/CD
nM/NN
,/,
70/CD
nM/NN
,/,
and/CC
0.5/CD
nM/NN
for/IN
hydrocortisone/NN
,/,
methylprednisolone/NN
,/,
and/CC
dexamethasone/NN
,/,
respectively/RB
,/,
in/IN
monocytes/NNS
from/IN
CS/JJ
individuals/NNS
./.
=====
There/EX
was/VBD
only/RB
weak/JJ
inhibition/NN
of/IN
the/DT
generation/NN
of/IN
enhancing/NN
activity/NN
by/IN
the/DT
corticosteroids/NNS
in/IN
the/DT
CR/JJ
asthmatic/JJ
individuals/NNS
./.
=====
The/DT
dexamethasone/NN
Kd/NN
was/VBD
2.45/CD
+/-/CC
0.58/CD
nM/NN
(/(
mean/NN
+/-/CC
SEM/NN
,/,
n/NN
=/JJ
6/CD
)/)
in/IN
the/DT
CS/JJ
group/NN
and/CC
1.6/CD
+/-/CC
0.35/CD
nM/NN
(/(
mean/NN
+/-/CC
SEM/NN
,/,
n/NN
=/JJ
6/CD
)/)
in/IN
the/DT
CR/JJ
group/NN
of/IN
patients/NNS
(/(
p/NN
=/JJ
0.14/CD
)/)
./.
=====
The/DT
Ro/NN
in/IN
the/DT
CS/JJ
group/NN
was/VBD
3,605/CD
+/-/CC
984/CD
binding/VBG
sites/NNS
per/IN
nucleus/NN
(/(
mean/NN
+/-/CC
SEM/NN
,/,
n/NN
=/JJ
6/CD
)/)
and/CC
4,757/CD
+/-/CC
692/CD
binding/VBG
sites/NNS
per/IN
nucleus/NN
(/(
mean/NN
+/-/CC
SEM/NN
,/,
n/NN
=/JJ
6/CD
)/)
in/IN
the/DT
CR/JJ
group/NN
(/(
p/NN
=/JJ
0.23/CD
)/)
./.
=====
These/DT
findings/NNS
indicate/VBP
that/IN
corticosteroid/NN
resistance/NN
in/IN
bronchial/JJ
asthma/NN
can/MD
not/RB
be/VB
explained/VBN
by/IN
abnormalities/NNS
in/IN
corticosteroid/NN
receptor/NN
characteristics/NNS
./.